Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry
Dual-energy X-ray absorptiometry (DXA) is the gold standard method for measuring bone
mineral density (BMD) which is most strongly associated with fracture risk. BMD is therefore …
mineral density (BMD) which is most strongly associated with fracture risk. BMD is therefore …
A practical approach for anabolic treatment of bone fragility with romosozumab
Background Romosozumab, a fully humanized anti-sclerostin-antibody, is a bone-builder
stimulating osteoblasts and inhibiting osteoclast by activation of the canonical Wnt-beta …
stimulating osteoblasts and inhibiting osteoclast by activation of the canonical Wnt-beta …
Romosozumab Followed by Denosumab Versus Denosumab Only: A Post Hoc Analysis of FRAME and FRAME Extension
F Cosman, M Oates, D Betah… - Journal of Bone and …, 2024 - academic.oup.com
Osteoanabolic-first treatment sequences are superior to oral bisphosphonates for fracture
reduction and BMD gain. However, data comparing osteoanabolic medications with the …
reduction and BMD gain. However, data comparing osteoanabolic medications with the …
Goal-Directed Osteoporosis Treatment: ASBMR/BHOF Task Force Position Statement 2024
F Cosman, EM Lewiecki, R Eastell… - Journal of Bone and …, 2024 - academic.oup.com
The overarching goal of osteoporosis management is to prevent fractures. A goal-directed
approach to long-term management of fracture risk helps ensure that the most appropriate …
approach to long-term management of fracture risk helps ensure that the most appropriate …
[HTML][HTML] Clinical Studies On Romosozumab: An Alternative For Individuals With A High Risk Of Osteoporotic Fractures: A Current Concepts Review (Part II)
EC Rodriguez-Merchan, A Moreno-Garcia… - …, 2023 - surgicoll.scholasticahq.com
Romosumab (ROMO) should be used to treat postmenopausal women with osteoporosis at
high fracture risk after carefully considering the cardiovascular status and the risk/benefit …
high fracture risk after carefully considering the cardiovascular status and the risk/benefit …
What's New in Osteoporosis: Emphasis on the Aging Athlete
The contemporary treatment of osteoporosis has seen tremendous evolution. Today, we
have access to powerful biologic agents for the treatment of osteoporosis and an improved …
have access to powerful biologic agents for the treatment of osteoporosis and an improved …